|
2024
|
Invention
|
Compositions for fecal floral transplantation and methods for making and using them and device fo... |
|
|
Invention
|
Microbiome related immunotherapies. The present invention generally relates to therapeutic compos... |
|
|
Invention
|
Compositions and methods for decolonizing antibiotic-resistant bacteria in the gut.
The present ... |
|
|
Invention
|
Compositions and methods for treating epilepsy and related disorders.
The present disclosure is ... |
|
2023
|
Invention
|
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making... |
|
|
Invention
|
Compositions for fecal floral transplantation and methods for making and using them and devices f... |
|
|
Invention
|
Compositions and methods for maintaining and restoring a healthy gut barrier.
The present invent... |
|
2022
|
Invention
|
Compositions and methods for providing secondary bile acids to a subject.
The present disclosure... |
|
|
Invention
|
Compositions and methods for providing secondary bile acids to a subject. The present disclosure ... |
|
2021
|
Invention
|
Compositions and method for treating primary sclerosing cholangitis and related disorders.
The p... |
|
|
Invention
|
Methods for treating autism spectrum disorder and associated symptoms.
The present disclosure re... |
|
|
Invention
|
Methods and compositions for treating ulcerative colitis. The present disclosure provides methods... |
|
|
Invention
|
Methods for treating ulcerative colitis.
The present disclosure provides methods and treatment r... |
|
|
Invention
|
Compositions and methods for treating diverticulitis and related disorders. The present disclosur... |
|
|
Invention
|
Compositions and methods for treating multiple sclerosis and related disorders.
The present disc... |
|
|
Invention
|
Compositions comprising non-viable fecal microbiota and methods of use thereof.
The present disc... |
|
|
Invention
|
Compositions comprising non-viable fecal microbiota and methods of use thereof. The present discl... |
|
|
Invention
|
Compositions and methods for non-alcoholic steatohepatitis (nash). The present disclosure is in t... |
|
|
Invention
|
Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv). The present disclo... |
|
|
Invention
|
Compositions and methods for treating hepatic encephalopathy (he). The present disclosure is in t... |
|
2020
|
Invention
|
Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders.
Th... |
|
|
Invention
|
Compositions and methods for treating neurodegenerative diseases. The present disclosure relates ... |
|
|
Invention
|
Compositions and methods for delivering a bacterial metabolite to a subject.
The present disclos... |
|
|
Invention
|
Compositions and methods for delivering a bacterial metabolite to a subject. The present disclosu... |
|
|
Invention
|
Compositions and methods for treating autism spectrum disorder.
The present disclosure relates t... |
|
|
Invention
|
Compositions and methods for treating autism spectrum disorder. The present disclosure relates to... |
|
|
Invention
|
Probiotic recolonisation therapy.
The present invention relates to pharmaceutical compositions s... |
|
|
Invention
|
Methods and products for treatment of gastrointestinal disorders.
Described herein are compositi... |
|
|
Invention
|
Methods and products for treatment of gastrointestinal disorders. Described herein are compositio... |
|
2019
|
Invention
|
Compositions and methods for treating epilepsy and related disorders. The present disclosure is i... |
|
2018
|
Invention
|
Fecal microbiota transplantation for treating ulcerative colitis.
The present disclosure provide... |
|
|
Invention
|
Compositions and methods for maintaining and restoring a healthy gut barrier. The present inventi... |
|
|
Invention
|
Treatment of liver disease by modulation of the microbiome.
The present invention relates to, in... |
|
2017
|
Invention
|
Compositions and methods for treating irritable bowel syndrome and related disorders.
The presen... |
